AKT1 and cancer: Mechanistically, through interacting with CD36, ApoC2 induces the activation of the PI3K/AKT/mTOR signaling pathway, promoting the over-expression of EMT markers and confer mesenchymal phenotype of GC cells and eventually foster cancer metastasis.